Oric Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.97; its P/E ratio is -5.46; Oric Pharmaceuticals is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -28.33M	$ -25.48M	$ -22.94M	$ -23.95M	$ -22.12M
EBITDA	$ -30.22M	$ -27.14M	$ -23.95M	$ -24.55M	$ -22.46M
Net Income Common Stockholders	$ -28.33M	$ -25.48M	$ -22.94M	$ -23.95M	$ -20.85M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 208.19M	$ 227.30M	$ 264.16M	$ 189.63M	$ 206.27M
Total Assets	$ 252.01M	$ 274.33M	$ 291.82M	$ 226.65M	$ 247.18M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -208.19M	$ -227.30M	$ -264.16M	$ -189.63M	$ -206.27M
Total Liabilities	$ 27.92M	$ 26.92M	$ 23.02M	$ 23.84M	$ 24.83M
Stockholders Equity	$ 224.09M	$ 247.41M	$ 268.82M	$ 202.79M	$ 222.35M
Cash Flow	-
Free Cash Flow	$ -24.33M	$ -19.72M	$ -21.55M	$ -20.94M	$ -15.62M
Operating Cash Flow	$ -24.27M	$ -19.64M	$ -21.14M	$ -20.63M	$ -15.33M
Investing Cash Flow	$ 20.96M	$ -57.83M	$ -19.31M	$ 12.78M	$ 28.30M
Financing Cash Flow	$ 453.00K	$ 31.00K	$ 85.17M	-	$ 24.79M

Currency in USD

Oric Pharmaceuticals Earnings and Revenue History

Income Statement >

Oric Pharmaceuticals Debt to Assets

Balance Sheet >

Oric Pharmaceuticals Cash Flow

Cash Flow >

Oric Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing